Document Detail

Validity of Composite Outcomes in Meta-Analyses of Stroke Prevention Trials: The Case of Aspirin.
MedLine Citation:
PMID:  21576939     Owner:  NLM     Status:  Publisher    
Background: Aspirin has been reported to be less effective for secondary vascular prevention in patients with ischaemic stroke, compared with other high-risk populations. This contention is largely based on results of meta-analyses that used a composite outcome of vascular death, myocardial infarction and stroke, reporting a 13% relative risk reduction. In this study, we explore whether the summary relative risk reduction for this composite outcome is representative of estimates for each of the individual components of the composite. Study Selection: All randomised controlled trials comparing aspirin with placebo/control in patients following ischaemic stroke or transient ischaemic attack, beyond the acute period (2 weeks). Data Analysis: A fixed-effects model was used and summary risk ratios were calculated for each of the outcomes: vascular mortality, recurrent non-fatal stroke, non-fatal myocardial infarction, composite of the latter three outcomes, all-cause mortality and non-vascular mortality. Results: Ten trials (n = 9,168) were included. For the composite of non-fatal stroke, non-fatal myocardial infarction and vascular death, aspirin was associated with a 13% reduction in risk (risk ratio, RR: 0.87; 95% CI: 0.81-0.94). For individual components of the composite, aspirin reduced the risk of non-fatal ischaemic stroke (RR: 0.81; 95% CI: 0.72-0.90) and non-fatal myocardial infarction (RR: 0.68; 95% CI: 0.52-0.87), but not vascular death (RR: 0.97; 95% CI: 0.86-1.1). Aspirin did reduce the risk of non-vascular death (RR: 0.79; 95% CI: 0.66-0.95), though, and had a trend towards a reduced risk of all-cause mortality (RR: 0.91; 95% CI: 0.81-1.01). Conclusions: Following ischaemic stroke, aspirin does not reduce the risk of vascular death, but provides a significant reduction in non-fatal stroke, myocardial infarction and non-vascular death. Our findings would support presenting the effect of aspirin therapy on individual outcomes rather than a composite including vascular death.
Emer McGrath; Aengus O'Conghaile; John W Eikelboom; Sean F Dinneen; Colin Oczkowski; Martin J O'Donnell
Related Documents :
12673179 - Analysis of referral patterns, predictive accuracy, and impact on patient management of...
12186799 - Microvascular structural correlates of myocardial contrast echocardiography in patients...
11550249 - Gd-dtpa bolus tracking in the myocardium using t1 fast acquisition relaxation mapping (...
10439729 - Pulmonary transit of sonicated albumin microbubbles during controlled mechanical ventil...
11323779 - Renal infarct: contrast-enhanced power doppler sonographic findings.
16645409 - Slow coronary flow and stress myocardial perfusion imaging. different patterns in acute...
10598899 - Development and evaluation of a new canine myocardial infarction model using a closed-c...
24145329 - Cyp2j2-derived eets suppress er stress in heart failure.
2481189 - Effects of pinacidil on myocardial blood flow and infarct size after acute left anterio...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-11
Journal Detail:
Title:  Cerebrovascular diseases (Basel, Switzerland)     Volume:  32     ISSN:  1421-9786     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-17     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9100851     Medline TA:  Cerebrovasc Dis     Country:  -    
Other Details:
Languages:  ENG     Pagination:  22-27     Citation Subset:  -    
Copyright Information:
Copyright © 2011 S. Karger AG, Basel.
National University of Ireland, Galway, Ireland.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Mania and Stroke: A Systematic Review.
Next Document:  First Experiences with a New Device for Mechanical Thrombectomy in Acute Basilar Artery Occlusion.